DANSPOT: A Multicenter Stepped‐Wedge Cluster‐Randomized Trial of the Reclassification of Acute Myocardial Infarction: Rationale and Study Design
Authors:
- Nina StrandkjærNSNina Strandkjær
- Rasmus Bo HasselbalchRHRasmus Bo Hasselbalch
- Jonas KristensenJKJonas Kristensen
- Thilde Olivia KockTKThilde Olivia Kock
- Theis LangeTLTheis Lange
- Matias Greve LindholmMLMatias Greve Lindholm
- Niels Eske BruunNBNiels Eske Bruun
- Christian Juhl TerkelsenCTChristian Juhl Terkelsen
- Claus Kjær PedersenCPClaus Kjær Pedersen
Open Access
- 7 May 2024
- journal article
- research article
- Published by Wolters Kluwer Health in Journal of the American Heart Association
- Vol. 13 (9) , e033493
Abstract
Background: Cardiac troponins are the preferred biomarkers for the diagnosis of acute myocardial infarction. Although sex‐specific 99th percentile thresholds of troponins are recommended in international guidelines, the clinical effect of their use is poorly investigated. The DANSPOT Study (The Danish Study of Sex‐ and Population‐Specific 99th percentile upper reference limits of Troponin) aims to evaluate the clinical effect of a prospective implementation of population‐ and sex‐specific diagnostic thresholds of troponins into clinical practice. Methods: This study is a nationwide, multicenter, stepped‐wedge cluster‐randomized trial of the implementation of population‐ and sex‐specific thresholds of troponins in 22 of 23 clinical centers in Denmark. We established sex‐specific thresholds for 5 different troponin assays based on troponin levels in a healthy Danish reference population. Centers will sequentially cross over from current uniform manufacturer‐derived thresholds to the new population‐ and sex‐specific thresholds. The primary cohort is defined as patients with symptoms suggestive of acute coronary syndrome having at least 1 troponin measurement performed within 24 hours of arrival with a peak troponin value between the current uniform threshold and the new sex‐specific female and male thresholds. The study will compare the occurrence of the primary outcome, defined as a composite of nonfatal myocardial infarction, unplanned revascularization, and all‐cause mortality within 1 year, separately for men and women before and after the implementation of the new sex‐specific thresholds. Conclusions: The DANSPOT Study is expected to show the clinical effects on diagnostics, treatment, and clinical outcomes in patients with myocardial infarction of implementing sex‐specific diagnostic thresholds for troponin based on a national Danish reference population. Registration: URL: https://www.clinicaltrials.gov ; Unique identifier: NCT05336435.Keywords
This publication has 34 references indexed in Scilit:
- Diagnostic and Management Dilemmas in Women Presenting with Acute Coronary SyndromesCurrent Cardiology Reports, 2020
- Sex-specific effects of implementing a high-sensitivity troponin I assay in patients with suspected acute coronary syndrome: results from SWEDEHEART registryScientific Reports, 2020
- Sex-Specific Thresholds of High-Sensitivity Troponin in Patients With Suspected Acute Coronary SyndromeJACC, 2019
- High-sensitivity troponin in the evaluation of patients with suspected acute coronary syndrome: a stepped-wedge, cluster-randomised controlled trialThe Lancet, 2018
- Cardiac troponin I levels in patients with non–ST-elevation acute coronary syndrome—The importance of genderAmerican Heart Journal, 2014
- Age- and Sex-Dependent Upper Reference Limits for the High-Sensitivity Cardiac Troponin T AssayJACC, 2014
- Strengths and weaknesses of a stepped wedge cluster randomized design: its application in a colorectal cancer follow-up studyJournal of Clinical Epidemiology, 2014
- Classification of Myocardial Infarction: Frequency and Features of Type 2 Myocardial InfarctionThe American Journal of Medicine, 2013
- Gender differences and normal left ventricular anatomy in an adult population free of hypertensionJACC, 2002
- Influence of Statistical Method Used on the Resulting Estimate of Normal RangeClinical Chemistry, 1971